mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |